Clinical Trials Directory

Trials / Completed

CompletedNCT02650232

Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex Sensitivity

Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex Sensitivity in Healthy Subjects and in Patients With Heart Failure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

To measure the spontaneous baroreflex sensitivity in ambulatory patient, a device made for measuring blood pressure beat by beat and continuously, the SOMNOtouch system, could be a useful tool. The SOMNOtouch system has never been used to assess the sensitivity of the baroreflex. A good correlation for measuring the baroreflex sensitivity between the system "SOMNOtouch" and digital photoplethysmography as a reference method is expected but should be evaluated. The main purpuse is to evaluate the SOMNOtouch system to quantify the spontaneous baroreflex sensitivity in healthy young subjects, in elderly healthy subjects and in subjects with heart failure. We will also evaluate the feasibility of measuring the baroreflex sensitivity in ambulatory conditions for 24 hours, the variations in sensitivity of the baroreflex sensitivity between day and night, the reproducibility of orthostatic tolerance test.

Conditions

Interventions

TypeNameDescription
DEVICESOMNOtouch device (Somnomedics)In each arm, we will evaluate the capacity of SOMNOtouch to measure the baroreflex sensitivity compared to Finapre Nova (reference)
PROCEDUREOrthostatic testFor each arm we will proceed to an orthostatic test day one and day two with : * 10 minutes in supine position * 10 minutes in sitting position * 5 minutes in standing position * 5 minutes in supine position
DEVICEFinapres Nova device (FMS system)

Timeline

Start date
2015-12-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2016-01-08
Last updated
2020-01-07

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02650232. Inclusion in this directory is not an endorsement.